Speakers

Expand/Collapse

Leona Bessonova
Director - HEOR
Alkermes

Day One

TUESDAY, SEPTEMBER 29

11:15 am | Opportunities for Patient Perspective Research Supporting Drug Development Lifecycle

9:00 am | Panel: Determining Where Value Lies in RWE

Michael Doane
Manager - HEOR
Alkermes

Day One

TUESDAY, SEPTEMBER 29

11:15 am | Opportunities for Patient Perspective Research Supporting Drug Development Lifecycle

Cathy Critchlow
Vice President, Center for Observational Research
Amgen

Day One

TUESDAY, SEPTEMBER 29

5:15 pm | Chair’s Closing Remarks & End of Day 1

8:50 am | Chair’s Opening Remarks

Day Two

WEDNESDAY, SEPTEMBER 30

4:00 pm | Chair’s Closing Remarks & End of Conference

9:45 am | Strategic Vision for RWE Generation Across the Product Lifecycle

8:55 am | Chair’s Opemimg Remarks

Glynn Dennis
Senior Director of Data Science
AstraZeneca

Day Two

WEDNESDAY, SEPTEMBER 30

11:30 am | Considerations for integrating digital and sensor data into the RWD ecosystem

Maarten Beekman
Respiratory Medical Director, International Region
AstraZeneca

Day One

TUESDAY, SEPTEMBER 29

4:15 pm | Case Study: RWE Global Opportunities & Emerging Markets

9:00 am | Panel: Determining Where Value Lies in RWE

David Anstatt
Executive Director, Center for Observational Research & Data Sciences
Bristol-Myers Squibb

Day One

TUESDAY, SEPTEMBER 29

2:45 pm | Understanding the Global RWE Regulatory Landscape

Day Two

WEDNESDAY, SEPTEMBER 30

9:00 am | Panel: Integration Within the Pharmaceutical Community

Dan Ollendorf
Director, Value Measurement & Global Health Initiatives
Center for the Evaluation of Value and Risk in Health (CEVR)

Day One

TUESDAY, SEPTEMBER 29

4:45 pm | Setting Standards for RWE in Comparative Effectiveness Research: Methods, Transparency & Governance

Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation

Day One

TUESDAY, SEPTEMBER 29

2:15 pm | Identifying Gaps in Current Patient Care Partnering to Accelerate Patient-Centric Real-World Evidence

9:00 am | Panel: Determining Where Value Lies in RWE

Dan Hennessy
Vice President, Medical Affairs
EMD Serono

Day One

TUESDAY, SEPTEMBER 29

1:45 pm | Interweaving RWE into the Strategic Fiber of Therapeutic Areas

9:00 am | Panel: Determining Where Value Lies in RWE

Tehseen Salimi
Vice President of Medical Affairs and Real World Evidence
G1 Therapeutics

Day One

TUESDAY, SEPTEMBER 29

9:45 am | Strategies for Leveraging Real World Data to Support Early Development and Value Proposition for Successful Product Launch

Francis Campion
Principal Lead
MITRE

Day Two

WEDNESDAY, SEPTEMBER 30

10:15 am | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform

Jason Walonoski
Department Head
MITRE

Day Two

WEDNESDAY, SEPTEMBER 30

10:15 am | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform

Patricia Schepman
Director, Global HEOR
Pfizer

Day One

TUESDAY, SEPTEMBER 29

3:45 pm | RWE Pre & Post Launch Elements

Sheena Thakkar
Manager, Global HEOR
Pfizer

Day One

TUESDAY, SEPTEMBER 29

3:45 pm | RWE Pre & Post Launch Elements

Miriam Fenton
Director, Real World Investigator
Sanofi

Day Two

WEDNESDAY, SEPTEMBER 30

12:00 pm | Strategic alignment of the question to the data

Frida Schain
CEO & Founder
Schain Research

Day One

TUESDAY, SEPTEMBER 29

9:00 am | Panel: Determining Where Value Lies in RWE

Day Two

WEDNESDAY, SEPTEMBER 30

2:00 pm | Strategizing Market Access - Ensuring Implementation for the Whole of the Drug Development Continuum

Amy Place
Senior Director, Field Medical Affairs
Scholar Rock

Day Two

WEDNESDAY, SEPTEMBER 30

3:00 pm | Global Medical Affairs (GMA): Lessons Learnt from Creating a Department

Javier Jimenez
Executive VP RWE & Late Phase
Syneos Health

Day One

TUESDAY, SEPTEMBER 29

11:45 am | How to Use RWE to Better Define Trial Protocol: Syneos’s Case Studies

Michael Lees
Head of Value, Evidence and Portfolio Strategy
Takeda

Day Two

WEDNESDAY, SEPTEMBER 30

9:00 am | Panel: Integration Within the Pharmaceutical Community

Ipek Stillman
Head Globak Health Economics
Takeda

Thomas Kristensen
Global Health Economics Lead Takeda
Takeda

Day One

TUESDAY, SEPTEMBER 29

12:15 pm | RWE and Patient Advocacy – Patient Centricity

Michael Lacey
Global Health Economics Lead
Takeda

Day One

TUESDAY, SEPTEMBER 29

12:15 pm | RWE and Patient Advocacy – Patient Centricity

Kevin Francis
Principal - Head of RWE, Insights & Analytics
Trinity

Day Two

WEDNESDAY, SEPTEMBER 30

1:30 pm | What is Normal? Using AI to Normalize & Control the Quality of Data Outputs

Omar Ali
Pharmacist Consultant
QIPP Adviser Payer Network

Day Two

WEDNESDAY, SEPTEMBER 30

3:30 pm | Understanding Market Access Methodology

Eric Klein
Senior Director, Oncology - Global Patient Outcomes and RWE
Eli Lilly and Company

Day Two

WEDNESDAY, SEPTEMBER 30

9:00 am | Panel: Integration Within the Pharmaceutical Community